Blood tests are simple, relatively non-invasive and cheap to perform, and serum HE4 and CA125 may have a role in screening and detection of those at high risk of endometrial cancer, and those in whom diagnosis is more challenging. The gene discussed is MUC16; the disease is endometrial cancer.